1HVC | pdb_00001hvc

CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å

wwPDB Validation 3D Report Full Report

Validation slider image for 1HVC

This is version 1.3 of the entry. See complete history

Literature

Crystal structure of a tethered dimer of HIV-1 proteinase complexed with an inhibitor.

Bhat, T.N.Baldwin, E.T.Liu, B.Cheng, Y.S.Erickson, J.W.

(1994) Nat Struct Biol 1: 552-556

  • DOI: https://doi.org/10.1038/nsb0894-552
  • Primary Citation Related Structures: 
    1HVC

  • PubMed Abstract: 

    HIV-1 proteinase (HIV PR) is a dimeric enzyme composed of two identical polypeptide chains that associate with twofold symmetry. We have determined to 1.8 A the crystal structure of a covalently tethered dimer of HIV PR. The tethered dimer:inhibitor complex is identical in nearly every respect to the complex of the same inhibitor with the wild type dimeric molecule, except for the linker region. Our results suggest that the tethered dimer may be a useful surrogate enzyme for studying the effects of single site mutations on substrate and inhibitor binding as well as on enzyme asymmetry, and for simulating independent mutational drift of the two domains which has been proposed to have led to the evolution of modern day, single-chain aspartic proteinases.


  • Organizational Affiliation
    • Structural Biochemistry Program, Frederick Biomedical Supercomputing Center, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.

Macromolecule Content 

  • Total Structure Weight: 22.76 kDa 
  • Atom Count: 1,667 
  • Modeled Residue Count: 203 
  • Deposited Residue Count: 203 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
HIV-1 PROTEASE203Human immunodeficiency virus 1Mutation(s): 0 
Gene Names: SYNTHETIC GENE
UniProt
Find proteins for Q4VE97 (Human immunodeficiency virus type 1)
Explore Q4VE97 
Go to UniProtKB:  Q4VE97
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ4VE97
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A79

Query on A79



Download:Ideal Coordinates CCD File
B [auth A]N-{1-BENZYL-(2S,3S)-2,3-DIHYDROXY-4-[3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRYLAMINO]-5-PHENYL-PENTYL}-3-METHYL-2-(3-METHYL-3-PYRIDIN-2-YLMETHYL-UREIDO)-BUTYRAMIDE
C44 H58 N8 O6
QPVWMQXBTCSLCB-UNHORJANSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.1α = 90
b = 59.8β = 90
c = 62.2γ = 90
Software Package:
Software NamePurpose
X-PLORmodel building
X-PLORrefinement
X-PLORphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 1994-10-15
    Type: Initial release
  • Version 1.1: 2008-03-10
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2024-02-07
    Changes: Data collection, Database references, Derived calculations, Other